TVTX
#1318
Travere Therapeutics, Inc. - Common Stock
52.1 3 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.17%
Variación mensual
-21.22%
Variación en los últimos 6 meses
+80.69%
Cambio anual
+81.20%
Cierres anteriores
52.0 4
Open
52.0 7
Mínimo
51.6 3
Máximo
52.7 1
Financials
- Market Capitalization 4.91 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-131.76
Relación precio/flujo de caja
6.95
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1287 |  SRRK Scholar Rock Holding Corporation - Common Stock | 42.19 USD | -0.02% | -10.29% | -25.34% | +40.54% | 5.14 B USD | ||
| 1308 |  DFTX Definium Therapeutics, Inc. - Common Shares | 36.90 USD | +7.96% | -1.60% | -15.17% | +144.21% | 4.96 B USD | ||
| 1366 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 82.37 USD | -0.07% | -6.86% | -23.98% | +138.34% | 4.61 B USD | ||
| 1420 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.06 USD | -0.43% | -5.99% | -11.19% | +156.47% | 4.24 B USD |